New RAS-mutant pancreatic adenocarcinoma with combined BRAF and MEK inhibition for metastatic melanoma

Carlino, M. S., Kwan, V., Miller, D. K., Saunders, C. A. B., Yip, D., Nagrial, A. M., … Long, G. V. (2015, April 1). New RAS-mutant pancreatic adenocarcinoma with combined BRAF and MEK inhibition for metastatic melanoma. Journal of Clinical Oncology. American Society of Clinical Oncology. https://doi.org/10.1200/JCO.2013.51.5783